查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1198148

PTA 球囊导管市场 - 增长、趋势、COVID-19 影响和预测 (2023-2028)

Pta Balloon Catheter Market - Growth, Trends, and Forecasts (2023 - 2028)
出版日期: | 出版商: Mordor Intelligence | 英文 111 Pages | 商品交期: 2-3个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

在预测期内（2022-2027 年），PTA 球囊导管市场预计将以 7.5% 左右的复合年增长率增长。

COVID-19 大流行的爆发导致就诊人数减少，从而减少了选择外科手术的患者数量，从而影响了市场的增长。 根据国家医学图书馆 2021 年发表的一项研究，与大流行前 (BC) 时期相比，大流行后 (AC) 时期与 ST 段抬高型心肌梗死 (STEMI) 相关，该活动导致血管造影术。它的特点是导致直接经皮冠状动脉介入治疗 (PPCI) 的激活次数显着减少。 STEMI 发病率的降低促使血管造影和 PPCI 的减少。 与大流行开始前相比，大流行开始后从门到气球 (D2B) 的时间平均增加了 20%。 因此，在大流行的早期阶段，COVID-19 对市场的影响是不利的。

心血管疾病和外周动脉疾病患病率上升、老年人口增加以及微创手术的使用增加是推动市场增长的一些主要因素。 在全球范围内，心脏病的发病率正在增加，这对人们的身心健康产生了负面影响。 因此，有效和先进的诊断和治疗程序的需求一直是 PTA 球囊导管。 因此，预计在预测期内市场将增加。 据欧洲心臟网2021年公布的数据显示，欧盟有超过6000万人患有心血管疾病，每年将诊断出近1300万心血管疾病新病例。 因此，由于心血管疾病的高发，介入心臟手术在世界范围内呈上升趋势。 因此，未来 PTA 球囊导管市场有望增长。

然而，导管通常会导致静脉血栓形成，从而导致肺栓塞，这在某些情况下可能是致命的。 血栓形成导致导管阻塞和导管尖端周围的薄护套腔内、静脉和附壁血栓。 由于反复使用导管，接受心导管术的患者发生导管相关血流感染的风险增加。 因此，与导管相关的风险和并发症可能会在未来几年阻碍 PTA 球囊导管的市场增长。 然而，这些可以通过技术进步来克服。

PTA球囊导管市场趋势

PTA球囊导管市场，冠心病领域有望占据较大市场份额

在过去的 30 年里，心血管疾病一直是全球死亡的主要原因。 久坐不动的生活方式是许多慢性疾病（如糖尿病和心血管疾病）的主要原因之一。 缺乏运动、饮酒和不健康食品以及吸烟等有害习惯已导致肥胖症流行，而肥胖症是各种心血管疾病的罪魁祸首。 治疗这些疾病的外科手术增加了对经皮腔内血管成形术 (PTA) 球囊导管的需求。 2021 年发表在 Pub Med Central 上的一项研究发现，冠状动脉疾病是全球死亡率和伤残调整生命年 (DALYs) 损失的首要原因。 这一负担大部分落在了低收入和中等收入国家身上，这些国家每年约有 12900 万 DALYs，而人群中冠状动脉疾病发病率的增加导致对导管的需求增加，导致预计在预测期内推动 PTA 球囊导管市场的增长。 例如，最近一项可能导致钙化血管治疗方式转变的创新是衝击波血管内碎石系统，该系统于 2021 年 2 月被美国食品和药物管理局 (FDA) 批准用于冠状动脉。 这涉及将低压气球连接到导管并发射声波能量以分解钙。

此外，波士顿科学公司正在进行美国首个药物涂层球囊（DCB）临床试验，以评估DCB在冠状动脉支架内再狭窄（ISR）患者中的安全性和有效性。宣布IDE考试“代理”已经启动。

这样，由于上述新兴市场的发展，预计该市场在预测期内将显着增长。

北美有望在预测期内主导市场

美国是全球受影响最严重的国家，因为泌尿系统和心血管疾病的患病率增加，预计对 PTA 球囊导管的需求将增加，从而预计将推动 PTA 球囊导管市场的增长。

这方面的背景是众多 PTA 球囊导管製造商、供应商和分销商的存在、心血管疾病的高患病率、先进医疗基础设施的存在以及患者对新兴微创手术意识的提高。有一些因素. 此外，对微创手术的日益偏好，如微创冠状动脉旁路移植术和微创心胸外科 (MICS)，也促进了北美市场的增长。 心脏病的流行预计将推动市场增长。 根据美国疾病控制与预防中心 (CDC) 的数据，2020 年 9 月，心脏病是美国最主要的心血管疾病。 每年约有 805,000 名美国人心脏病发作。 随着心脏病数量的增加，对满足未满足需求所需的适当治疗程序和设备的需求也在增加。 因此，预计在预测期内会出现增长。

此外，该地区创新产品的推出也促进了市场的增长。 例如，2021 年 6 月，Neurescue 的 NEURESCUE 设备获得了美国食品和药物管理局的 510k 许可，这是“世界上第一个智能球囊导管”，专为主动脉等大血管的临时闭塞而设计。

此外，不断上升的医疗保健成本和提高的疾病意识（尤其是在美国和加拿大）正在推动该地区整体市场的增长。

PTA 球囊导管市场竞争对手分析

PTA 球囊导管市场分散且竞争激烈，由几家大型企业组成。 从市场份额的角度来看，目前几家大型企业占据了市场主导地位。 目前主导市场的公司包括 Medtronic plc、Terumo Corporation、Cardinal Health、Boston Scientific Corporation、Natec Medical、AndraTec、Cook Medical、Biotronik、Abbot、Koninklijke Philips、B. Braun Melsungen AG、Becton、Cardionovum GmbH 等。

其他好处

  • Excel 格式的市场预测 (ME) 表
  • 3 个月的分析师支持

内容

第一章介绍

  • 研究假设和市场定义
  • 调查范围

第二章研究方法论

第 3 章执行摘要

第四章市场动态

  • 市场概览
  • 市场驱动力
    • 泌尿系统疾病和心血管疾病的患病率增加
    • 对微创手术的需求
    • 老龄化社会、缺乏运动和不健康的饮食习惯
  • 市场製约因素
    • 血管成形术费用高
    • 与导管相关的风险和并发症
  • 波特的五力分析
    • 新进入者的威胁
    • 买方/消费者议价能力
    • 供应商的议价能力
    • 替代品的威胁
    • 竞争公司之间的敌对关係

第五章市场细分（价值基础，单位：百万美元）

  • 按材料类型
    • 聚氨酯
    • 尼龙
  • 通过申请
    • 冠状动脉疾病
    • 外周血管疾病
  • 最终用户
    • 医院或诊所
    • 门诊手术中心
    • 其他
  • 按地区
    • 北美
      • 美国
      • 加拿大
      • 墨西哥
    • 欧洲
      • 德国
      • 英国
      • 法国
      • 意大利
      • 西班牙
      • 其他欧洲地区
    • 亚太地区
      • 中国
      • 日本
      • 印度
      • 澳大利亚
      • 韩国
      • 其他亚太地区
    • 中东
      • 海湾合作委员会
      • 南非
      • 其他中东地区
    • 南美洲
      • 巴西
      • 阿根廷
      • 其他南美洲

第六章竞争格局

  • 公司简介
    • Medtronic plc
    • Terumo Corporation
    • Cardinal Health
    • Boston Scientific Corporation
    • Natec Medical
    • AndraTec
    • Cook Medical
    • Biotronik
    • Abbot
    • Koninklijke Philips
    • B. Braun Melsungen AG
    • Becton
    • Cardionovum GmbH

第7章 市场机会今后动向

简介目录
Product Code: 90876

The PTA Balloon Catheter market is expected to register a CAGR of about 7.5% during the forecast period (2022-2027).

The onset of the COVID-19 pandemic has led to a reduction in the number of patient visits that reduced the number of patients opting for surgical procedures, thereby impacting the market growth. As per the study published by the National Library of Medicine in 2021, Compared to periods before initiation of pandemic (BC), the after initiation of pandemic (AC) period was characterized by a marked reduction in the number of activations for ST-elevation myocardial infarction (STEMI), number of activations leading to angiography and number of activations leading to primary percutaneous coronary intervention (PPCI). A decline in STEMI activations drove the reductions in angiography and PPCI volumes. Relative to periods before initiation of the pandemic, the door to balloon (D2B) times after initiation of the pandemic period increased on average by 20%. As a result, the impact of COVID-19 on the market was adverse during the initial phase of the pandemic.

The rising prevalence of cardiovascular disorders and peripheral artery disease, the growing geriatric population, and an increasing number of minimally invasive surgeries are some of the key factors boosting the market growth. Globally there has been an increase in the incidence of cardiac disease, which is negatively impacting people's physical and mental well-being. Thus, the demand for effective and advanced diagnostics and treatment procedures were PTA balloon catheters. Therefore, the market is expected to increase in the forecast period. According to the data published by the European Heart network in 2021 reported that in the European Union more than 60 million people live with Cardiovascular disease and close to 13 million new cases of cardiovascular diseases are diagnosed every year. Hence, due to the high frequency of cardiovascular diseases, interventional heart procedures are increasing around the world. As a result, the PTA balloon catheter market is expected to increase in the coming year.

However, catheters are often associated with vein thrombosis, which may lead to pulmonary embolism and, in some cases, may prove to be fatal. Thrombosis can result in obstruction of a catheter, which includes a fibrin sheath around the intraluminal, venous, and mural thrombosis at the catheter tip. Patients who undergo cardiac catheterization are at a higher risk of catheter-associated bloodstream infections due to repeated use of catheters. Therefore, risks and complications associated with catheters may impede the growth of the market for PTA Balloon Catheters in the coming years. However, they can be overcome with technological advancements.

PTA Balloon Catheter Market Trends

The Coronary Artery Disease Segment is Expected to Hold a Major Market Share in the PTA Balloon Catheter Market

Cardiovascular diseases have become the leading cause of death worldwide in the past three decades. A sedentary lifestyle is one of the major causes leading to many chronic disorders such as diabetes and cardiovascular ailments. Harmful habits such as lack of physical activity, consumption of alcohol and unhealthy food, and smoking have resulted in a growing prevalence of obesity, which in turn leads to various cardiovascular diseases. Surgical intervention for the treatment of such disorders has increased the demand for percutaneous transluminal angioplasty (PTA) balloon catheters. According to a study published by Pub Med Central in 2021, Coronary artery disease is the foremost single cause of mortality and loss of Disability Adjusted Life Years (DALYs) globally. A large number of this burden falls on low and middle-income countries accounting for nearly129 a million DALYs annually, with the growing incidence of coronary artery disease among the people expected to increase demand for catheters, which in turn is expected to drive the growth of the PTA balloon catheter market over the forecast period. For instance, a recent innovation that may offer a paradigm shift in how calcified vessels are treated is the Shockwave Intravascular Lithotripsy system approved by the Food and Drug Administration(FDA) in February 2021 for coronary artery use in February 2021. It combines a low-pressure balloon mounted on a catheter that delivers bursts of sonic energy to crack the calcium.

In addition to this, Boston Scientific Corporation announced it had initiated the AGENT IDE trial for the Agent Drug-Coated Balloon (DCB), the first clinical trial in the United States to evaluate the safety and effectiveness of a DCB in patients with coronary in-stent restenosis (ISR).

Thus, due to the above-mentioned developments, the market is expected to witness significant growth over the forecast period.

North America is Expected to Dominate the Market Over the Forecast Period

The United States is the most affected country across the world, as the increasing prevalence of urological and cardiovascular diseases is expected to increase demand for PTA balloon catheters, which in turn is expected to fuel the PTA balloon catheter market growth over the forecast period.

This can be attributed to factors such as the presence of a large number of PTA balloon catheter manufacturers, suppliers, and distributors, the high prevalence of cardiovascular disorders, the presence of sophisticated healthcare infrastructure, and an increase in patient awareness about emerging minimally invasive surgeries in the region. In addition, the growing preference for minimally invasive surgeries, such as minimally invasive coronary bypass and Minimally Invasive Cardiothoracic Surgery (MICS), is contributing to market growth in North America. The prevalence of cardiac diseases is expected to boost the growth of the market. Also, according to the Centres for Disease Control and Prevention (CDC), in September 2020, heart disease was the leading cardiovascular disease in the United States. Every year about 805,000 Americans has a heart attack. As the number of heart diseases is increasing, there is a growing demand for the proper treatment procedures and devices required to fulfill the unmet needs. Hence are expected to show growth over the forecast period.

Also, the innovative product launches in this region are contributing to the growth of the market. For instance, In June 2021, Neurescue received the 510k clearance from the United States Food and Drug Administration for their NEURESCUE device, 'the world's first intelligent balloon catheter,' devised for the temporary occlusion of large vessels such as the aorta.

Moreover, high expenditure on healthcare, especially in the United States and Canada, along with increased awareness about the disease, is fueling the growth of the overall regional market to a large extent. ​

PTA Balloon Catheter Market Competitor Analysis

The PTA Balloon Catheter market is fragmented and competitive and consists of several major players. In terms of market share, a few of the major players are currently dominating the market. Some of the companies which are currently dominating the market are Medtronic plc, Terumo Corporation, Cardinal Health, Boston Scientific Corporation, Natec Medical, AndraTec, Cook Medical, Biotronik, Abbot, Koninklijke Philips, B. Braun Melsungen AG, Becton, Cardionovum GmbH, and others.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Assumptions & Market Definition
  • 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Increasing Prevalence of Urological and Cardiovascular Diseases
    • 4.2.2 Demand for Minimally-Invasive Surgeries
    • 4.2.3 Growing Aging Population and Lack of Physical Activities and Unhealthy Diet
  • 4.3 Market Restraints
    • 4.3.1 High Cost of Angioplasty
    • 4.3.2 Risk and Complication Associated with Catheterization Procedures
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION (Market Size by Value - in USD Million)

  • 5.1 By Material Type
    • 5.1.1 Polyurethane
    • 5.1.2 Nylon
  • 5.2 By Application
    • 5.2.1 Coronary Artery Disease
    • 5.2.2 Peripheral Vascular Disease
  • 5.3 By End User
    • 5.3.1 Hospitals or Clinics
    • 5.3.2 Ambulatory Surgery Centers
    • 5.3.3 Others
  • 5.4 Geography
    • 5.4.1 North America
      • 5.4.1.1 United States
      • 5.4.1.2 Canada
      • 5.4.1.3 Mexico
    • 5.4.2 Europe
      • 5.4.2.1 Germany
      • 5.4.2.2 United Kingdom
      • 5.4.2.3 France
      • 5.4.2.4 Italy
      • 5.4.2.5 Spain
      • 5.4.2.6 Rest of Europe
    • 5.4.3 Asia-Pacific
      • 5.4.3.1 China
      • 5.4.3.2 Japan
      • 5.4.3.3 India
      • 5.4.3.4 Australia
      • 5.4.3.5 South Korea
      • 5.4.3.6 Rest of Asia-Pacific
    • 5.4.4 Middle-East
      • 5.4.4.1 GCC
      • 5.4.4.2 South Africa
      • 5.4.4.3 Rest of Middle-East
    • 5.4.5 South America
      • 5.4.5.1 Brazil
      • 5.4.5.2 Argentina
      • 5.4.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Medtronic plc
    • 6.1.2 Terumo Corporation
    • 6.1.3 Cardinal Health
    • 6.1.4 Boston Scientific Corporation
    • 6.1.5 Natec Medical
    • 6.1.6 AndraTec
    • 6.1.7 Cook Medical
    • 6.1.8 Biotronik
    • 6.1.9 Abbot
    • 6.1.10 Koninklijke Philips
    • 6.1.11 B. Braun Melsungen AG
    • 6.1.12 Becton
    • 6.1.13 Cardionovum GmbH

7 MARKET OPPORTUNITIES AND FUTURE TRENDS